Stocks That Hit 52-Week Lows On Tuesday
Tuesday's session saw 95 companies set new 52-week lows.
Watching ThermoGenesis; Traders Circulate Seeking Alpha Blog Post From Contributor Biotechlab’s Blog Titled ‘$THMO (ThermoGenesis Holdings, Inc.) Is Very Undervalued Company Especially When Compared To Its Peers With Market Caps Over 1 Billion Dollars….
https://seekingalpha.com/instablog/2694641-biotechlab/4944940-thmo-thermogenesis-holdings-inc-is-undervalued-company-especially-when-compared-to-peers
Earnings Scheduled For November 12, 2021
Companies Reporting Before The Bell
• Zevia (NYSE:ZVIA) is estimated to report quarterly loss at $0.43 per share on revenue of $34.40 million.
ThermoGenesis US Patent & Trademark Office Abstract Shows Co. Patent For ‘Buoyancy-activated cell sorting (BACS)-compatible activation/transduction systems and methods’
https://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&u=%2Fnetahtml%2FPTO%2Fsearch-adv.htm&r=6335&f=G&l=50&d=PTXT&p=127&S1=20211012&OS=20211012&RS=20211012
ThermoGenesis Holdings’s Return On Capital Employed Overview
ThermoGenesis Holdings (NASDAQ:THMO) brought in sales totaling $2.20 million during Q2 according to data provided by Benzinga Pro. However, earnings decreased 88.7%, resulting in a loss of $3.14 million.
Recap: ThermoGenesis Holdings Q2 Earnings
Shares of ThermoGenesis Holdings (NASDAQ:THMO) decreased 2.7% after the company reported Q2 results.
Quarterly Results
Earnings per share rose 62.75% over the past year to ($0.38), which missed the estimate of ($0.18).
ThermoGenesis Holdings Q2 EPS $(0.38) Misses $(0.18) Estimate, Sales $2.20M Beat $1.98M Estimate
ThermoGenesis Holdings (NASDAQ:THMO) reported quarterly losses of $(0.38) per share which missed the analyst consensus estimate of $(0.18) by 111.11 percent. This is a 62.75 percent increase over losses of $(1.02) per
The Daily Biotech Pulse: Xeris Gets OK For Initiating Hyperthyroidism Study, Merck-Eisai Snag FDA Approval For Drug Combo, Decision Day For Jazz Pharma
Here's a roundup of top developments in the biotech space over the last 24 hours:
Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs Aug. 11)